Global strategy for asthma management and prevention: GINA executive summary.

PubWeight™: 10.08‹?› | Rank: Top 0.1%

🔗 View Article (PMID 18166595)

Published in Eur Respir J on January 01, 2008

Authors

E D Bateman1, S S Hurd, P J Barnes, J Bousquet, J M Drazen, M FitzGerald, P Gibson, K Ohta, P O'Byrne, S E Pedersen, E Pizzichini, S D Sullivan, S E Wenzel, H J Zar

Author Affiliations

1: University of Cape Town Lung Institute, PO Box 34560, Groote School, 7700 Mowbray, Cape Town, South Africa. ebateman@uctgsh1.uct.ac.za

Associated clinical trials:

Impact of a Curriculum Intervention on Asthma Knowledge in Adolescents of a Public School in Salvador-Bahia-Brazil (KARE) | NCT02142179

Control and Burden of Asthma and Rhinitis (ICAR) | NCT01771120

Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics | NCT01420003

Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics | NCT00992667

Effects of CPAP in Severe Therapy-resistant Asthma (CPAP-STRA) | NCT03215303

A Study Into Airways Disease Case Finding and Management (ASSIST) | NCT03355677

Articles citing this

(truncated to the top 100)

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol (2010) 3.54

Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol (2010) 3.22

Do Patients of Subspecialist Physicians Benefit from Written Asthma Action Plans? Am J Respir Crit Care Med (2015) 3.14

Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med (2014) 2.56

Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol (2010) 2.27

Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax (2009) 2.12

Glucocorticosteroids: current and future directions. Br J Pharmacol (2011) 1.85

Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration (2011) 1.78

Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma. Proc Natl Acad Sci U S A (2009) 1.77

Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J (2014) 1.74

Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model. Clin Exp Allergy (2013) 1.70

Bronchodilator activity of bitter tastants in human tissue. Nat Med (2011) 1.69

Qualitative analysis of high-resolution CT scans in severe asthma. Chest (2009) 1.52

Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol (2013) 1.51

The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly. J Allergy (Cairo) (2011) 1.49

MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One (2009) 1.44

Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol (2013) 1.43

Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study. Mayo Clin Proc (2014) 1.42

Diagnosis of asthma in adults. CMAJ (2009) 1.41

Treatment of allergic asthma: modulation of Th2 cells and their responses. Respir Res (2011) 1.31

Alternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thickness. J Immunol (2012) 1.30

The role of leptin in the respiratory system: an overview. Respir Res (2010) 1.30

β(2) -adrenoceptor agonists: current and future direction. Br J Pharmacol (2011) 1.30

Novel long-acting bronchodilators for COPD and asthma. Br J Pharmacol (2008) 1.28

Biochemical basis of asthma therapy. J Biol Chem (2011) 1.24

Current control and future risk in asthma management. Allergy Asthma Immunol Res (2011) 1.22

High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med (2011) 1.19

EP4 receptor as a new target for bronchodilator therapy. Thorax (2011) 1.16

Effectiveness of pharmacopuncture for asthma: a systematic review and meta-analysis. Evid Based Complement Alternat Med (2010) 1.15

The microbiology of asthma. Nat Rev Microbiol (2012) 1.14

Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma. Respiration (2010) 1.13

Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians. Osteoporos Int (2009) 1.13

The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med (2014) 1.11

Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can Respir J (2009) 1.11

Therapeutic options for severe asthma. Arch Med Sci (2012) 1.11

Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more. Int J Chron Obstruct Pulmon Dis (2011) 1.10

Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. Respir Res (2012) 1.08

Stress and Bronchodilator Response in Children with Asthma. Am J Respir Crit Care Med (2015) 1.06

Perinatal cat and dog exposure and the risk of asthma and allergy in the urban environment: a systematic review of longitudinal studies. Clin Dev Immunol (2011) 1.06

Transient receptor potential (TRP) channels in the airway: role in airway disease. Br J Pharmacol (2014) 1.05

Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect Dis (2013) 1.05

Cancer risk in hospitalised asthma patients. Br J Cancer (2009) 1.04

Sub-lingual immunotherapy: world allergy organization position paper 2009. World Allergy Organ J (2009) 1.03

Allergen-induced airway inflammation and its therapeutic intervention. Allergy Asthma Immunol Res (2009) 1.02

A nationwide survey of inhalant allergens sensitization and levels of indoor major allergens in Korea. Allergy Asthma Immunol Res (2014) 1.02

Achieving control of asthma in preschoolers. CMAJ (2009) 1.01

Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide. Br J Pharmacol (2012) 1.01

Must family physicians use spirometry in managing asthma patients?: YES. Can Fam Physician (2010) 1.00

Mesenchymal stem cell transfer suppresses airway remodeling in a toluene diisocyanate-induced murine asthma model. Allergy Asthma Immunol Res (2011) 1.00

The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study. J Asthma Allergy (2012) 0.98

Failure in asthma control: reasons and consequences. Scientifica (Cairo) (2013) 0.98

New data analysis in a population study raises the hypothesis that particle size contributes to the pro-asthmatic potential of small pet animal allergens. Ups J Med Sci (2015) 0.98

Misdiagnosis of patients receiving inhaled therapies in primary care. Int J Chron Obstruct Pulmon Dis (2010) 0.98

Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol (2011) 0.97

Management of asthma in Benin: the challenge of loss to follow-up. Public Health Action (2013) 0.96

IL-17-producing peripheral blood CD177+ neutrophils increase in allergic asthmatic subjects. Allergy Asthma Clin Immunol (2013) 0.96

Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial). Can Respir J (2009) 0.95

Factors associated with patient visits to the emergency department for asthma therapy. BMC Pulm Med (2012) 0.95

Safety of investigative bronchoscopy in the Severe Asthma Research Program. J Allergy Clin Immunol (2011) 0.95

Current recommendations for the treatment of mild asthma. J Asthma Allergy (2010) 0.95

Reduced severity and improved control of self-reported asthma in Finland during 2001-2010. Asia Pac Allergy (2015) 0.95

Measurement of asthma control according to Global Initiative for Asthma guidelines: a comparison with the Asthma Control Questionnaire. Respir Res (2012) 0.95

Airway Measurement for Airway Remodeling Defined by Post-Bronchodilator FEV1/FVC in Asthma: Investigation Using Inspiration-Expiration Computed Tomography. Allergy Asthma Immunol Res (2010) 0.95

Strategies used by older adults with asthma for adherence to inhaled corticosteroids. J Gen Intern Med (2014) 0.94

Respiratory and mental health effects of wildfires: an ecological study in Galician municipalities (north-west Spain). Environ Health (2011) 0.94

An understanding of the genetic basis of asthma. Indian J Med Res (2011) 0.94

Origins of increased airway smooth muscle mass in asthma. BMC Med (2013) 0.94

Prevalence of asthma in Portugal - The Portuguese National Asthma Survey. Clin Transl Allergy (2012) 0.94

Is respiratory viral infection really an important trigger of asthma exacerbations in children? Eur J Pediatr (2011) 0.94

Development, evaluation and validation of a new instrument for measurement quality of life in the parents of children with chronic disease. Health Qual Life Outcomes (2010) 0.94

β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids. Proc Natl Acad Sci U S A (2011) 0.94

Galectin-3: its role in asthma and potential as an anti-inflammatory target. Respir Res (2013) 0.93

General practice variation in spirometry testing among patients receiving first-time prescriptions for medication targeting obstructive lung disease in Denmark: a population-based observational study. BMC Fam Pract (2013) 0.93

IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells. Respir Res (2013) 0.92

How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan. Respir Res (2012) 0.92

Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis (2016) 0.91

Poor asthma education and medication compliance are associated with increased emergency department visits by asthmatic children. Ann Thorac Med (2015) 0.91

Airway imaging in disease: gimmick or useful tool? J Appl Physiol (1985) (2012) 0.91

Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications. J Allergy Clin Immunol (2014) 0.91

Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time. Clin Transl Allergy (2012) 0.90

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.90

Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis. J Korean Med Sci (2011) 0.90

Repression of TNF-alpha-induced IL-8 expression by the glucocorticoid receptor-beta involves inhibition of histone H4 acetylation. Exp Mol Med (2009) 0.90

Level of asthma control and its impact on activities of daily living in asthma patients in Brazil. J Bras Pneumol (2013) 0.90

Stressful life events and the onset of asthma. Eur Respir J (2010) 0.90

Immunopathogenesis of allergic asthma: more than the th2 hypothesis. Allergy Asthma Immunol Res (2013) 0.90

Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer. World J Gastroenterol (2014) 0.90

Attenuation of antigen-induced airway hyperresponsiveness and inflammation in CXCR3 knockout mice. Respir Res (2011) 0.89

Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis. Clinics (Sao Paulo) (2009) 0.89

CD4+ T cells enhance the unloaded shortening velocity of airway smooth muscle by altering the contractile protein expression. J Physiol (2014) 0.89

Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection. PLoS One (2014) 0.89

CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responses. Allergy (2010) 0.89

Childhood asthma and vitamin D deficiency in Turkey: is there cause and effect relationship between them? Ital J Pediatr (2013) 0.89

Quality of asthma management in an urban community in Delhi, India. Indian J Med Res (2012) 0.89

Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can Respir J (2011) 0.89

Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center study. J Allergy Clin Immunol (2016) 0.89

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer. PLoS One (2013) 0.89

Pulmonary findings in Churg-Strauss syndrome in chest X-rays and high resolution computed tomography at the time of initial diagnosis. Clin Rheumatol (2010) 0.89

Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population. BMC Med Genet (2011) 0.88

Single center experience of five diffuse panbronchiolitis patients clinically presenting as severe asthma. J Korean Med Sci (2015) 0.88

Articles by these authors

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48

Sponsorship, authorship, and accountability. Lancet (2001) 7.10

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA (2001) 6.55

Sponsorship, authorship, and accountability. N Engl J Med (2001) 6.20

Sponsorship, authorship and accountability. CMAJ (2001) 5.86

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care (2001) 5.61

Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (1996) 5.53

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med (2001) 5.47

Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39

Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25

Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07

Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest (1999) 4.66

Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) (1998) 4.31

Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics (1987) 4.10

The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85

Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest (2000) 3.84

Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med (1998) 3.83

Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest (1995) 3.78

Large voltage-induced magnetic anisotropy change in a few atomic layers of iron. Nat Nanotechnol (2009) 3.75

In vitro effects on microtubule dynamics of purified Xenopus M phase-activated MAP kinase. Nature (1991) 3.59

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA (1998) 3.57

Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet (2001) 3.48

Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med (1999) 3.44

Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest (1998) 3.37

Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet (1996) 3.35

Asthma as an axon reflex. Lancet (1986) 3.26

Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA (1999) 3.24

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA (2001) 3.21

Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet (1982) 3.21

Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. Proc Natl Acad Sci U S A (1980) 3.18

A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16

Exhaled markers of pulmonary disease. Am J Respir Crit Care Med (2001) 3.14

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol (2000) 3.13

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J (2006) 3.09

The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol (2001) 3.08

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med (2000) 3.08

Neural control of human airways in health and disease. Am Rev Respir Dis (1986) 2.97

Distinct roles of two separable in vitro activities of yeast Mre11 in mitotic and meiotic recombination. EMBO J (1998) 2.94

Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A (1980) 2.94

Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93

The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med (1994) 2.90

Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework. Lancet (2000) 2.87

Successful treatment of Behçet disease with pentoxifylline. Ann Intern Med (1996) 2.81

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J (1997) 2.79

Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med (1997) 2.77

Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax (1998) 2.71

Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70

Sponsorship, authorship, and accountability. Ann Intern Med (2001) 2.66

What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65

Exacerbations of chronic obstructive pulmonary disease. Eur Respir J (2007) 2.65

Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol (1985) (1988) 2.64

Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis (1987) 2.64

Cytokines in asthma. Thorax (1999) 2.64

Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A (1993) 2.64

Purification and characterization of an enzyme produced by Treponema denticola capable of hydrolyzing synthetic trypsin substrates. Infect Immun (1986) 2.62

Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J (2003) 2.57

Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51

Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity. Biochem Biophys Res Commun (1980) 2.49

Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol (2000) 2.48

Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47

The costs of treating COPD in the United States. Chest (2001) 2.43

Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A (1994) 2.41

Non-prescription use of bronchodilator aerosols. Med J Aust (1992) 2.41

Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet (1986) 2.41

Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36

Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34

Transbronchial biopsy as a tool to evaluate small airways in asthma. Eur Respir J (2002) 2.33

Phylogeny of nitrogenase sequences in Frankia and other nitrogen-fixing microorganisms. J Mol Evol (1989) 2.33

Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med (2000) 2.33

Active anaphylaxis in IgE-deficient mice. Nature (1994) 2.32

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med (1992) 2.32

Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med (1996) 2.32

Obesity in total hip replacement. J Bone Joint Surg Br (2008) 2.29

Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med (1995) 2.28

Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy (2002) 2.26

Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med (2000) 2.25

The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med (1994) 2.23

Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. J Pediatr (2001) 2.23

Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy (2007) 2.22

Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22

Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 2.20

Exhaled carbon monoxide in childhood asthma. J Pediatr (1999) 2.19

Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med (1998) 2.19

Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J (2001) 2.18

The Republican and Democratic candidates speak on health care. N Engl J Med (2000) 2.18

Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J (2004) 2.18

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Effects of intravenous administration of slow-reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2alpha on pulmonary mechanics in the guinea pig. J Clin Invest (1974) 2.16

Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13